Integrative Metabolomics Differentiate Coronary Artery Disease, Peripheral Artery Disease, and Venous Thromboembolism Risks.
Jiwoo LeeThomas C GillilandJacqueline S DronSatoshi KoyamaTetsushi NakaoKim LanneryMegan WongGina M PelosoWhitney E HornsbyPradeep NatarajanPublished in: Arteriosclerosis, thrombosis, and vascular biology (2024)
While common vascular conditions are associated with overlapping metabolomic profiles, MR prioritized the role of specific lipoprotein species for potential pharmacological targets to maximize benefits in both arterial and venous beds.
Keyphrases
- peripheral artery disease
- venous thromboembolism
- coronary artery disease
- human health
- direct oral anticoagulants
- mass spectrometry
- risk assessment
- percutaneous coronary intervention
- cardiovascular events
- contrast enhanced
- magnetic resonance
- coronary artery bypass grafting
- low density lipoprotein
- magnetic resonance imaging
- genetic diversity
- type diabetes
- network analysis
- cardiovascular disease
- computed tomography
- left ventricular
- aortic stenosis